Haleos Labs logo

Haleos Labs financials: balance sheet, profit and loss, cash flow

NSE: HALEOSLABSBSE: 540679Pharmaceuticals & BiotechnologySmall Cap

HALEOS LABS LIMITED · Formerly SMS Lifesciences India · Face value ₹10 · Listed Aug 2017
Last close ₹1,474.00up ₹10.30 (0.70%)BSE ₹1,492.70

Share price at the NSE close on 27 Oct 2026. Previous close ₹1,463.70.

27 Oct: open ₹1,474.40, high ₹1,475.00, low ₹1,449.80

52-week range of traded prices to 27 Oct 2026
₹1,091.10Low, 30 Jan 2026₹1,774.00High, 11 May 2026
Market cap
₹446 Cr1,954th largest listed
P/E
28.20
P/B
2.09
Dividend yield
0.10%
ROE
7.7%
ROCE
7.4%
Debt to equity
0.47
Volume, NSE
1,59490.3% delivered

Haleos Labs' financial statements for the 9 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them.

9 years at a glance

₹ crore, years to March.Haleos Labs annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
2176.5Mar 183441740Mar 192579.145Mar 202601342Mar 213462560Mar 223151385Mar 233001389Mar 243332179Mar 253011893Mar 26
Peak revenue ₹346 Cr, year to Mar 2022; lowest ₹217 Cr, year to Mar 2018

Operating and net margin, per cent

  • Operating margin
  • Net margin
13.4%3.0%6.1%9.4%9.3%11.4%9.1%8.4%11.5%13.3%13.4%3.0%4.8%3.6%5.1%7.3%4.2%4.4%6.4%5.9%Mar 18Mar 20Mar 22Mar 24Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 1.8% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue301
  2. Materials and goods−139
  3. Employee costs−49
  4. Other expenses−72
  5. Operating profit40
  6. Depreciation−11
  7. Other income+1.4
  8. One-off items0.0
  9. Finance costs−6.0
  10. Profit before tax25
  11. Tax−7.4
  12. Net profit18

What the company owns

  • Plant, investments and other assets₹278 Cr
  • Inventory₹70 Cr
  • Receivables₹54 Cr
  • Cash and bank₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹215 Cr
  • Borrowings₹93 Cr
  • Owed to suppliers₹54 Cr
  • Other liabilities₹42 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Haleos Labs quarterly results

₹ croreMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 MayJun 2026Twelve monthsFiled 5 Aug
Revenue from operations217344257260346315300333301290
204312233231314289266289261252
Materials and goods bought133230162140208190162169139132
Employee costs–212327333538464950
Other expenses–614864736465747270
Operating profit before depreciation13322430312634444038
Operating margin6.1%9.4%9.3%11.4%9.1%8.4%11.5%13.3%13.4%13.2%
Materials, % of revenue–66.9%63.1%53.7%60.3%60.4%54.1%50.7%46.2%45.4%
Employee costs, % of revenue–6.0%9.1%10.4%9.4%11.0%12.6%13.7%16.4%17.3%
Other expenses, % of revenue–17.7%18.6%24.5%21.2%20.3%21.8%22.3%23.9%24.1%
Depreciation and amortisation66778810101111
Operating profit after depreciation7271723231824343027
Other income3321234412
Finance costs4555559866
Profit before one-off items and tax6241319201619302523
One-off items–0001320000
Profit before tax6241319331819302523
0746856977
Net profit717913251313211816
Other comprehensive income–000000000
Total comprehensive income–17913251313211816
Net margin3.0%4.8%3.6%5.1%7.3%4.2%4.4%6.4%5.9%5.5%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
105113126151164176197215
Share capital33333333
Reserves102110123148161173194212
4045426085897993
10880105119111123124133
3736414263483756
Total assets251229272312337347358403
121128136150170173181222
130101135162168174178182
Net debt3842335884877892
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
21.6−14.71.914.828.038.4
26.23.48.817.829.443.4
−3.0−37.9−17.4−6.2−11.07.5
Receivables−7.9−4.0−12.3−3.9−20.210.7
Inventories2.3−22.60.95.914.0−9.2
Payables16.014.9−16.3−5.0−3.67.8
Other working capital−13.4−26.310.3−3.2−1.2−1.7
Tax paid−4.60.00.0−3.08.5−6.5
Interest paid0.0−7.63.50.00.02.1
Capital spending13.325.033.913.714.149.2
Free cash flow8.3−39.6−32.01.013.9−10.8
−5.9−7.5−28.0−13.7−13.8−49.3
−7.914.625.3−0.8−14.210.8
Dividends paid0.00.50.50.50.50.5
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash7.8−7.5−0.80.20.10.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Haleos Labs dividend history

₹ per shareMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
Earnings per share₹21.50₹55.02₹30.26₹43.56₹83.95₹43.72₹43.22₹70.69₹58.80
Diluted earnings per share₹21.50₹55.02₹30.26₹43.56₹83.95₹43.72₹43.22₹70.69₹58.80
Dividend per share–₹1.50–₹1.50₹1.50₹1.50₹1.50₹1.50₹1.50
Book value per share–₹347.23₹374.61₹417.88₹500.16₹542.55₹582.90₹652.19₹709.74
Dividend payout–2.7%–3.4%1.8%3.4%3.5%2.1%2.6%
Shareholder yield–––0.0%0.2%0.3%0.2%0.1%0.1%
Market cap at the year end (₹ crore)11616854149211154204326361

Ratios

Standalone, years to March.Haleos Labs PE ratio and valuation

RatioMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 29 May
Revenue growth–58.2%−25.3%1.3%32.8%−8.8%−4.8%11.1%−9.7%
Operating profit growth–145.9%−26.7%25.0%5.5%−15.8%30.4%28.5%−8.5%
Net profit growth–155.9%−45.0%44.0%92.7%−47.9%−1.2%63.6%−16.8%
Earnings per share growth–155.9%−45.0%44.0%92.7%−47.9%−1.1%63.6%−16.8%
–15.8%8.4%11.0%18.3%8.4%7.7%11.4%8.6%
––−7.5 pts2.6 pts7.3 pts−9.9 pts−0.7 pts3.8 pts−2.8 pts
From the net margin––−4.2 pts3.5 pts5.0 pts−7.8 pts0.3 pts3.6 pts−0.9 pts
From asset turnover––−2.6 pts−0.4 pts2.2 pts−1.9 pts−0.8 pts0.9 pts−1.7 pts
From borrowing––−0.7 pts−0.6 pts0.1 pts−0.2 pts−0.2 pts−0.7 pts−0.2 pts
Return on capital employed–18.4%10.5%13.4%11.1%7.3%9.1%12.3%9.7%
Cash conversion–––164.2%−57.7%14.2%112.9%131.2%216.2%
Interest cover1.84.93.35.05.13.62.74.34.9
Debt to equity–0.380.390.330.400.520.500.400.43
Receivable days–3931423653607166
Inventory days–117138154143154168131183
Payable days–13210214712410511199141
Cash conversion cycle, days–24674854102116102108
Working capital days–33575978110135125127
Asset turnover–1.371.071.041.180.970.880.940.79
Assets per rupee of net worth–2.392.202.092.102.062.011.891.85
Sales per rupee of plant–3.952.752.603.592.292.212.251.60
Capital spending to depreciation–––1.853.124.151.341.374.62
Plant being built, % of plant in use–1.5%2.6%3.1%22.0%0.6%4.4%0.3%0.7%
No balance sheet is on record for the year to Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
4.7%
Cash from operations against operating profit
95.0%
Measure10 years5 years3 years
Revenue growth, yearly rate–3.0%−1.5%
Profit growth, yearly rate–6.2%10.4%
Return on equity, average–10.9%9.3%
Return on capital employed, average–9.9%10.4%
Operating margin, average10.2%11.1%12.7%
Net margin, average5.0%5.6%5.6%
Asset turnover, average–0.950.87
Cash conversion cycle, days, average–97109
Interest cover, average3.94.14.0
Debt to equity, average–0.450.45

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations688138
Cash from investing−112−77−49
Cash from financing36−411
Capital spending1367749
Dividends paid210
Shares bought back000
Shares issued for cash000
Borrowings raised1005231
Borrowings repaid433811

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Effective tax ratePublished threshold 17.16 per cent−1.64––––––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
22 May 2026Infomerics Valuation and Ratings Private LimitedLong Term/ Short Term RatingIVR BBB/ IVR A3+Review, Re-affirmPositive116.01
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.